Site: 119 — New London, Connecticut

Site: 119 is a clinical research site located in New London, Connecticut, United States 06320.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site: 119 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Peripheral Neuropathy, Pain.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site: 119?

Site: 119 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site: 119 conducted?

Site: 119 has 1 clinical trials on record. Their work covers Diabetic Peripheral Neuropathy, Pain.

Is Site: 119 accredited by Crixeo Health?

Site: 119 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site: 119?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.